|
WO2018069924A1
|
|
Non-cytotoxic combination therapies and uses thereof in the treatment of cancer
|
|
WO2016166761A1
|
|
Combination therapies and uses thereof in the treatment of cancer
|
|
IL233495D0
|
|
Combination therapy for the treatment of cancer
|
|
CA2860473A1
|
|
Combination therapy for the treatment of cancer
|
|
IL209106D0
|
|
Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases
|
|
EP2285369A2
|
|
Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases
|
|
IL196381D0
|
|
Anti-cancer therapeutic composition and kit comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
|
|
AU2007270686A1
|
|
Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent
|
|
CN101068561A
|
|
Method and composition for enhancing anti-angiogenic therapy
|
